ESKETAMINE HYDROCHLORIDE NASAL SPRAY (Spravato®)

Clinical Indication

In combination with a SSRI or SNRI for adults with treatment-resistant Major Depressive Disorder

Comments

Subject to LPT Managed Entry Requirements

Date of classification

February 2020

Review date

February 2020

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).